Literature DB >> 21139373

Simultaneous application of combination of three surgical techniques for treatment of gingival recession: a case report.

Tatiana Miranda Deliberador1, Felipe Rychuv Santos, Alvaro Francisco Bosco, Flávia Aparecida Chaves Furlaneto, Michel Reis Messora, Allan Fernando Giovanini, Maria José Hitomi Nagata.   

Abstract

The treatment of Miller class III gingival recession is considered a challenge in periodontal practice, and among the different techniques used, autogenous connective tissue graft has shown the most favorable results. In some cases, more than one procedure may be necessary. In this case report, we describe the simultaneous application of a combination of three techniques (the tunnel technique, a connective tissue graft and a laterally positioned flap) to treat a Miller class III gingival recession localized in the lower anterior region. Twelve months after surgical procedures, partial root coverage, favorable esthetic results and a gain in clinical attachment level were observed, with no periodontal pockets or bleeding on probing.

Entities:  

Mesh:

Year:  2010        PMID: 21139373     DOI: 10.2209/tdcpublication.51.201

Source DB:  PubMed          Journal:  Bull Tokyo Dent Coll        ISSN: 0040-8891


  2 in total

1.  Evaluation of 2 techniques of epithelial removal in subepithelial connective tissue graft surgery: a comparative histological study.

Authors:  Paola Marques de Mattos; Vula Papalexiou; Vinícius Augusto Tramontina; Sung Hyun Kim; Sônia Mara Luczyszyn; Patrícia Vida Cassi Bettega; Aline Cristina Batista Rodrigues Johann
Journal:  J Periodontal Implant Sci       Date:  2019-11-04       Impact factor: 2.614

2.  Complete root coverage in the treatment of Miller class III or RT2 gingival recessions: a systematic review and meta-analysis.

Authors:  Aitziber Fernández-Jiménez; Ana-María García-De-La-Fuente; Ruth Estefanía-Fresco; Xabier Marichalar-Mendia; José-Manuel Aguirre-Urizar; Luis-Antonio Aguirre-Zorzano
Journal:  BMC Oral Health       Date:  2021-03-22       Impact factor: 2.757

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.